HCM - CIK 0001648257
The table below shows HUTCHMED (China) Ltd's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2019 | Q1 2018 |
|---|---|---|
| Operating cash flow | -$28.92M | -$30.84M |
| Capital expenditure | $1.36M | $1.32M |
| Investing cash flow | $33.38M | $27.71M |
| Dividends paid | - | - |
| Stock buybacks | $346.00K | $5.45M |
| Financing cash flow | -$346.00K | -$5.23M |
HUTCHMED (China) Ltd reported operating cash flow of -$64.66M for fiscal year 2025. That is down 13109.5% from $497.00K in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$9.57M (FY 2016) to -$64.66M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.